Don't Just Read the News, Understand It.
Published loading...Updated

Women aged 30 could be offered breast cancer checks in NHS trial

  • An NHS trial based in Manchester is offering breast cancer risk evaluations to women aged 30 to 39, led by the consultant who previously treated Girls Aloud’s Sarah Harding.
  • The trial follows Sarah Harding’s death from breast cancer in 2021 and aims to identify younger women at increased risk who currently fall outside routine screening age.
  • The study combines mammograms, DNA tests, and questionnaires to calculate risk scores, finding about 19% of 548 women analyzed at elevated risk comparable to women aged 50 and over.
  • Girls Aloud bandmates expressed their pride in the study conducted in Sarah Harding’s memory, highlighting its important role in detecting women without symptoms who may benefit from early preventative care.
  • Plans are underway to expand the trial nationwide, supporting a national cancer plan to improve early diagnosis and possibly lower screening age from 50 to 30.
Insights by Ground AI
Does this summary seem wrong?

7 Articles

All
Left
Center
2
Right
4
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources lean Right
67% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Daily Express broke the news in United Kingdom on Friday, May 30, 2025.
Sources are mostly out of (0)